Ojocef TZ 1.125

Product Description

Ojocef TZ 1.125 Injection contains Ceftriaxone 1000 mg and Tazobactam 125 mg, a powerful combination used for the treatment of moderate to severe bacterial infections, including resistant cases.

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftriaxone by preventing bacterial resistance. This combination offers broad-spectrum coverage against a wide range of infection-causing organisms.

Key Benefits

• Broad-spectrum antibiotic for severe infections
• Effective against resistant bacteria
• Dual action enhances antibacterial efficacy
• Helps control infection and prevent spread
• Promotes faster recovery

Key Ingredients

• Ceftriaxone 1000 mg – Cephalosporin antibiotic
• Tazobactam 125 mg – Beta-lactamase inhibitor

Indications

• Respiratory tract infections
• Urinary tract infections
• Intra-abdominal infections
• Skin and soft tissue infections
• Gynecological infections
• Septicemia

Dosage / Administration

• Administered via intravenous or intramuscular route
• Dosage as directed by a physician
• Use under strict medical supervision

Precautions

• Use under medical supervision
• Check for cephalosporin or penicillin allergy
• Monitor liver and kidney function
• Not effective in viral infections
• Complete full course as prescribed
• Store as per label instructions
• Keep out of reach of children